Page 1 | Search Results | Clinical Cancer Research | American Association for Cancer Research

1-4 of 4

Sort by

Sort Order Select

Journal Articles

Selinexor Combined with Ibrutinib Demonstrates Tolerability and Safety in Advanced B-Cell Malignancies: A Phase I Study

Deborah M. Stephens, Ying Huang, Amy S. Ruppert, Janek S. Walker, Daniel Canfield, Casey B. Cempre, Qiang Fu, Sharyn Baker, Boyu Hu, Harsh Shah, Renee Vadeboncoeur, Kerry A. Rogers, Seema Bhat, Samantha M. Jaglowski, Hank Lockman, Rosa Lapalombella, John C. Byrd, Jennifer A. Woyach

Clin Cancer Res (2022) 28 (15): 3242–3247.

https://doi.org/10.1158/1078-0432.CCR-21-3867

Published: 02 August 2022

View article titled, Selinexor Combined with Ibrutinib Demonstrates Tolerability and Safety in Advanced B-Cell Malignancies: A Phase I Study

Includes: Supplementary data

Journal Articles

A Pharmacokinetic/Pharmacodynamic Model of Tumor Lysis Syndrome in Chronic Lymphocytic Leukemia Patients Treated with Flavopiridol

Jia Ji, Diane R. Mould, Kristie A. Blum, Amy S. Ruppert, Ming Poi, Yuan Zhao, Amy J. Johnson, John C. Byrd, Michael R. Grever, Mitch A. Phelps

Clin Cancer Res (2013) 19 (5): 1269–1280.

https://doi.org/10.1158/1078-0432.CCR-12-1092

Published: 03 March 2013

View article titled, A Pharmacokinetic/Pharmacodynamic Model of Tumor Lysis Syndrome in Chronic Lymphocytic Leukemia Patients Treated with Flavopiridol

Includes: Supplementary data

Journal Articles

Gene Expression Profiling Reveals Similarities between the In vitro and In vivo Responses of Immune Effector Cells to IFN-α

Jason M. Zimmerer, Gregory B. Lesinski, Amy S. Ruppert, Michael D. Radmacher, Carl Noble, Kari Kendra, Michael J. Walker, William E. Carson, III

Clin Cancer Res (2008) 14 (18): 5900–5906.

https://doi.org/10.1158/1078-0432.CCR-08-0846

Published: 14 September 2008

View article titled, Gene Expression Profiling Reveals Similarities between the In vitro and In vivo Responses of Immune Effector Cells to IFN-α

Includes: Supplementary data

Journal Articles

IFN-α-2b–Induced Signal Transduction and Gene Regulation in Patient Peripheral Blood Mononuclear Cells Is Not Enhanced by a Dose Increase from 5 to 10 Megaunits/m²

Jason M. Zimmerer, Amy M. Lehman, Amy S. Ruppert, Carl W. Noble, Thomas Olencki, Michael J. Walker, Kari Kendra, William E. Carson, III

Clin Cancer Res (2008) 14 (5): 1438–1445.

https://doi.org/10.1158/1078-0432.CCR-07-4178

Published: 03 March 2008

View article titled, IFN-α-2b–Induced Signal Transduction and Gene Regulation in Patient Peripheral Blood Mononuclear Cells Is Not Enhanced by a Dose Increase from 5 to 10 Megaunits/m2

NARROW

Selinexor Combined with Ibrutinib Demonstrates Tolerability and Safety in Advanced B-Cell Malignancies: A Phase I Study

A Pharmacokinetic/Pharmacodynamic Model of Tumor Lysis Syndrome in Chronic Lymphocytic Leukemia Patients Treated with Flavopiridol

Gene Expression Profiling Reveals Similarities between the In vitro and In vivo Responses of Immune Effector Cells to IFN-α

IFN-α-2b–Induced Signal Transduction and Gene Regulation in Patient Peripheral Blood Mononuclear Cells Is Not Enhanced by a Dose Increase from 5 to 10 Megaunits/m²

Email alerts

AACR Journals

Selinexor Combined with Ibrutinib Demonstrates Tolerability and Safety in Advanced B-Cell Malignancies: A Phase I Study

A Pharmacokinetic/Pharmacodynamic Model of Tumor Lysis Syndrome in Chronic Lymphocytic Leukemia Patients Treated with Flavopiridol

Gene Expression Profiling Reveals Similarities between the In vitro and In vivo Responses of Immune Effector Cells to IFN-α

IFN-α-2b–Induced Signal Transduction and Gene Regulation in Patient Peripheral Blood Mononuclear Cells Is Not Enhanced by a Dose Increase from 5 to 10 Megaunits/m2

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only

IFN-α-2b–Induced Signal Transduction and Gene Regulation in Patient Peripheral Blood Mononuclear Cells Is Not Enhanced by a Dose Increase from 5 to 10 Megaunits/m²